Chemistry: molecular biology and microbiology – Vector – per se
Patent
1987-04-13
1990-02-06
Tanenholtz, Alvin E.
Chemistry: molecular biology and microbiology
Vector, per se
4351723, 935 13, 536 27, C12N 100, C12N 1500
Patent
active
048988308
ABSTRACT:
Described are methods and means for the construction and microbial expression of quasi-synthetic genes arising from the combination of organic synthesis and enzymatic reverse transcription from messenger RNA sequences incomplete from the standpoint of the desired protein product. Preferred products of expression lack bio-inactivating leader sequences common in eukaryotic expression products but problematic with regard to microbial cleavage to yield bioactive material. Illustrative is a preferred embodiment in which a gene coding for human growth hormone (useful in, e.g., treatment of hypopituitary dwarfism) is constructed and expressed.
REFERENCES:
patent: 4363877 (1982-12-01), Goodman et al.
patent: 4601980 (1986-07-01), Goeddel et al.
patent: 4604359 (1986-08-01), Goeddel et al.
patent: 4634677 (1987-01-01), Goeddel et al.
Itakwa et al, Science, vol. 198, pp. 1056-1063, Dec. 1977.
Polisky et al, PNAS USA, vol. 73, pp. 3900-3904, Nov. 1976.
Backman et al, Cell vol. 13, pp. 65-71, Jan. 1978.
Seeburg et al, Nature, vol. 276, pp. 795-798, Dec. 1978.
Villa-Komanoff et al, PNAS USA, vol. 75, pp. 3727-3731, Aug. 1978.
Goeddel David V.
Heyneker Herbert L.
Buting Walter E.
Genentech Inc.
Tanenholtz Alvin E.
LandOfFree
Human growth hormone DNA does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human growth hormone DNA, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human growth hormone DNA will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-441665